However, since the small molecule Galectin-1 inhibitor PXT008 was able to sensitize BCP-ALL cells to vincristine [28], endogenous Galectin-1 still appears to be of major significance for BCP-ALL cells that express it in high quantities. This evidence concerns the gene LGALS1 and acute lymphoblastic leukemia.